RedHill Biopharma Shares Up 9.8%; Yesterday Co. Announced Co-Promotion Agreement With Jaguar Health's Napo Pharm, Giving RedHill The Right To Co-Promote Mytesi In The U.S.; RedHill Expects To Initiate Its Promotion 'In the coming weeks'
Benzinga Newsdesk